Embedded Files
TissueGenix enables precision multicellular 3D human tissue models with AI-assisted design translation, rapid 3D bioprinting, short culture windows, and well-to-well consistency, while maintaining compatibility with standard plate-based assays.
Why TissueGenix
Fast design-to-assay in standard multiwell plates
Rapid biofabrication and short culture windows
Well-to-well consistency for assay robustness
Conventional 2D culture often lacks the physiological complexity needed for translationally meaningful readouts, while many conventional 3D approaches (such as spheroids) can require weeks of culture before they are ready for assays. In addition, these models are often heterogenous in size, shape, and composition, which compromises their scalability and reproducibility.
TissueGenix uses a bottom-up bioprinting platform engineered for speed, precision, and well-to-well consistency in standard multiwell plates. Our workflows are designed to generate structured multicellular tissue constructs with rapid fabrication, short culture windows, and plate-compatible assay readiness, supporting faster iteration, reduced workflow friction, and improved cost-efficiency. AI-assisted design translation and ML-supported phenotyping are in development through early collaborations.
*Timelines depend on model types and assay design; details are available upon request.
The Power of 3D Bioprinting
Precision manufacturing
Reproducible performance
Adaptability with common plate formats and readouts
Precision
TissueGenix's bioprinting platform enables high‑precision patterning of cells and biomaterials in micro-scale, allowing us to build structured tissue blocks with controlled architecture. This level of control enables the recreation of spatial organization and microenvironment context in vitro, supporting clear, interpretable readouts in plate-based assays.
Reproducibility
The bioprinting platform is designed for repeatable, standardized fabrication, producing tissue constructs with consistent geometry and composition from well to well. By prioritizing process control and stable build parameters, the platform supports reliable assay performance and reduces variability that can complicate screening and model development.
Adaptability
Our platform is design-friendly and configurable, allowing tissue designs to be adjusted to match different biological questions and assay needs. This adaptability supports applications from screening and assay development to disease modeling. The compatibility with conventional multiwell plate workflows also facilitate the integration with existing workflow and readout systems.
AI-Enabled Workflow
AI-assisted design translation
ML-based image analysis and phenotyping
Automated QC and standardized reporting
AI-enabled capabilities are in development and being advanced through early collaborations.
Page updated
Google Sites
Report abuse